查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387997

2024 年智慧藥丸全球市場報告

Smart Pills Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

2023年智慧藥丸市場最大的地區是北美。西歐是智慧藥丸市場分析的第二大地區。智慧藥丸市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

目錄

第1章 執行摘要

第2章 智慧藥丸市場特點

第3章 智慧藥丸市場趨勢與策略

第4章 智慧藥丸市場 – 宏觀經濟情勢

第5章 全球智慧藥丸市場規模與成長

  • 全球智慧藥丸市場的驅動與抑制因素
    • 市場驅動力
    • 市場抑制因素
  • 2018-2023年全球智慧藥丸市場規模、實績與成長
  • 2023-2028年至2033年全球智慧藥丸市場規模與成長預測

第6章 智慧藥丸市場區隔

  • 全球智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 食道疾病
  • 結腸疾病
  • 小腸疾病
  • 其他疾病的適應症
  • 全球智慧藥丸市場，依目標領域、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 食道
  • 胃
  • 小腸
  • 大腸
  • 全球智慧藥丸市場，依應用區隔、實績和預測，2018-2023、2023-2028、直至 2033 年
  • 膠囊內視鏡
  • 病人監護
  • 藥物輸送
  • 全球智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年
  • 醫院
  • 診斷中心
  • 研究機構

第7章 智慧藥丸市場區域與國家分析

  • 全球智慧藥丸市場，依地區、實績和預測，2018-2023、2023-2028、至 2033
  • 全球智慧藥丸市場，依國家、實績及預測，2018-2023、2023-2028、至 2033 年

第8章 亞太智慧藥丸市場

  • 亞太地區智慧藥丸市場概況
  • 區域資訊、COVID-19 影響、市場資訊、背景資訊、政府配合措施、法規、監管機構、關鍵機構、課稅、公司稅務結構、投資、主要企業
  • 亞太地區智慧藥丸市場，依疾病適應症區隔，實績及預測，2018-2023年、2023-2028年、至2033年
  • 亞太地區智慧藥丸市場，依目標區域區隔，實績和預測，2018-2023 年、2023-2028 年、直至 2033 年
  • 亞太地區智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第9章 中國智慧藥丸市場

  • 中國智慧藥丸市場概況
  • 中國智慧藥丸市場，依疾病適應症區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 中國智慧藥丸市場，依目標區域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 中國智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023年、2023-2028年、直至2033年

第10章 印度智慧藥丸市場

  • 印度智慧藥丸市場，依疾病適應症區隔，實績與預測，2018-2023年、2023-2028年、至2033年
  • 印度智慧藥丸市場，依目標區域區隔，實績和預測，2018-2023年、2023-2028年、直至2033年
  • 印度智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第11章日本智慧藥丸市場

  • 日本智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 日本智慧藥丸市場，依目標區域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 日本智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第12章澳洲智慧藥丸市場

  • 澳洲智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年至2033年
  • 澳洲智慧藥丸市場，依目標區域區隔，實績和預測，2018-2023、2023-2028、直至 2033 年
  • 澳洲智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第13章印尼智慧藥丸市場

  • 印尼智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 印尼智慧藥丸市場，依目標區域區隔、實績和預測，2018-2023年、2023-2028年，直至2033年
  • 印尼智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023 年、2023-2028 年，直至 2033 年

第14章韓國智慧藥丸市場

  • 韓國智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 韓國智慧藥丸市場，依目標區域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 韓國智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第15章西歐智慧藥丸市場

  • 西歐智慧藥丸市場概況
  • 西歐智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 西歐智慧藥丸市場，依目標區域、實績及預測區隔，2018-2023年、2023-2028年，直至2033年
  • 西歐智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第16章英國智慧藥丸市場

  • 英國智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年至2033年
  • 英國智慧藥丸市場，依目標地點區隔，實績和預測，2018-2023 年、2023-2028 年、直至 2033 年
  • 英國智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第17章德國智慧藥丸市場

  • 德國智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 德國智慧藥丸市場，依目標地點區隔，實績和預測，2018-2023 年、2023-2028 年，直至 2033 年
  • 德國智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023 年、2023-2028 年，直至 2033 年

第18章法國智慧藥丸市場

  • 法國智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 法國智慧藥丸市場，依目標區域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 法國智慧藥丸市場，依最終用戶區隔，實績及預測，2018-2023年、2023-2028年，直至2033年

第19章義大利智慧藥丸市場

  • 義大利智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 義大利智慧藥丸市場，依目標地點區隔，實績及預測，2018-2023年、2023-2028年，直至2033年
  • 義大利智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直到 2033 年

第20章西班牙智慧藥丸市場

  • 西班牙智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 西班牙智慧藥丸市場，依目標地點區隔，實績和預測，2018-2023年、2023-2028年，直至2033年
  • 西班牙智慧藥丸市場，依最終用戶區隔，實績及預測，2018-2023年、2023-2028年，直至2033年

第21章東歐智慧藥丸市場

  • 東歐智慧藥丸市場概況
  • 東歐智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023、2023-2028、至 2033 年
  • 東歐智慧藥丸市場，依目標地點區隔，實績和預測，2018-2023、2023-2028、直到 2033 年
  • 東歐智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第22章俄羅斯智慧藥丸市場

  • 俄羅斯智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 俄羅斯智慧藥丸市場，依目標領域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 俄羅斯智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直到 2033 年

第23章北美智慧藥丸市場

  • 北美智慧藥丸市場概況
  • 北美智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 北美智慧藥丸市場，依目標區域區隔、實績及預測，2018-2023年、2023-2028年，直至2033年
  • 北美智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第24章美國智慧藥丸市場

  • 美國智慧藥丸市場概況
  • 美國智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 美國智慧藥丸市場，依目標領域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 美國智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第25章加拿大智慧藥丸市場

  • 加拿大智慧藥丸市場概況
  • 加拿大智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年至2033年
  • 加拿大智慧藥丸市場，依目標地點區隔，實績和預測，2018-2023 年、2023-2028 年、直至 2033 年
  • 加拿大智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第26章南美智慧藥丸市場

  • 南美洲智慧藥丸市場概況
  • 南美智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 南美智慧藥丸市場，依目標區域區隔、實績及預測，2018-2023年、2023-2028年，至2033年
  • 南美洲智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直到 2033 年

第27章巴西智慧藥丸市場

  • 巴西智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 巴西智慧藥丸市場，依目標地點區隔，實績和預測，2018-2023 年、2023-2028 年，直至 2033 年
  • 巴西智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023 年、2023-2028 年，直至 2033 年

第28章中東智慧藥丸市場

  • 中東智慧藥丸市場概況
  • 中東智慧藥丸市場，依疾病適應症區隔，實績與預測，2018-2023年、2023-2028年，直到2033年
  • 中東智慧藥丸市場，依目標區域區隔，實績和預測，2018-2023、2023-2028、直到 2033 年
  • 中東智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第29章非洲智慧藥丸市場

  • 非洲智慧藥丸市場概況
  • 非洲智慧藥丸市場，依疾病適應症、實績及預測區隔，2018-2023年、2023-2028年，至2033年
  • 非洲智慧藥丸市場，依目標區域區隔，實績和預測，2018-2023年、2023-2028年，直到2033年
  • 非洲智慧藥丸市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、直至 2033 年

第30章智慧藥丸市場競爭形勢及公司概況

  • 智慧藥丸市場競爭形勢
  • 智慧藥丸市場公司概況
    • Medtronic plc
    • Olympus Corporation
    • CapsoVision Inc.
    • Novartis AG
    • Proteus Digital Health Inc

第31章全球智慧藥丸市場競爭基準化分析

第32章全球智慧藥丸市場競爭儀表板

第33章智慧藥丸市場主要併購

第34章智慧藥丸市場未來展望及可能性分析

第35章附錄

簡介目錄
Product Code: r9239

“Smart Pills Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart pills? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The smart pills market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine
  • 2) By Disease Indication: Esophageal Diseases, Colon Diseases, Small bowel Diseases, and Other Disease Indications
  • 3) By Application: Capsule Endoscopy; Patient Monitoring; Drug Delivery
  • 4) By End User: Hospital; Diagnostic Center; Research Institute
  • Companies Mentioned: Medtronic plc; Olympus Corporation; CapsoVision Inc.; Novartis AG; Proteus Digital Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Smart pills are designed for the purpose of administering medication and are equipped with electronic sensors that emit signals detectable by patches or smartphones upon ingestion. These innovative pills play a crucial role in ensuring patients' adherence to their prescribed drug regimens and enable the monitoring of medication compliance.

The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.

The smart pills market research report is one of a series of new reports from The Business Research Company that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart pills market size has grown rapidly in recent years. It will grow from $4.98 billion in 2023 to $5.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%.

The expansion observed in the historical period can be attributed to factors such as the focus on medication adherence, the management of chronic diseases, the involvement of smart pills in clinical trials and research, and the impact of an aging population.

The smart pills market size is expected to see rapid growth in the next few years. It will grow to $8.49 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The anticipated growth in the forecast period can be linked to remote patient monitoring, the influence of regulatory and quality standards, continued utilization of smart pills in clinical trials and research, and the integration of digital health technologies. Notable trends expected during the forecast period encompass wireless health monitoring, the development of diagnostic and imaging capsules, the utilization of data analytics and artificial intelligence, advancements in smart pill sensors, and the emphasis on miniaturization and biocompatibility.

The smart pills market is experiencing growth, driven by the increasing preference for non-invasive procedures. Non-invasive procedures refer to diagnostic and treatment methods that do not require incisions or tissue removal. Smart pills, which are wireless, ingestible capsules, are easily swallowed and have a wide range of applications in capsule endoscopy, drug delivery, and patient monitoring. For example, they play a crucial role in diagnostic imaging, particularly in capsule endoscopy, a procedure where a smart pill with a micro-camera is swallowed to capture images of the esophagus, stomach, and small intestine as it traverses the gastrointestinal (GI) tract. Smart pills have transformed the diagnosis of gastrointestinal disorders and have the potential to replace conventional techniques like endoscopy. Consequently, the preference for non-invasive procedures is a key driver of the smart pills market.

The growth of the smart pills market is expected to be further fueled by the increasing prevalence of gastrointestinal disorders. Gastrointestinal disorders affect the digestive system, including the stomach, intestines, and associated organs. Smart pills equipped with sensors and technology are utilized for monitoring and diagnosing gastrointestinal disorders, providing valuable insights into digestive system function. For example, as of September 2022, the National Library of Medicine reports that over 40% of people worldwide experience gastrointestinal problems such as diarrhea, constipation, and irritable bowel syndrome (IBS), with prevalence rates of 4.7%, 11.7%, and 4.1%, respectively. Therefore, the rising incidence of gastrointestinal disorders is a significant driver of the smart pills market.

The high cost of smart pills associated with technological advancements poses a restraint to market growth. The integration of advanced technologies, including software upgrades and innovative systems, and the incorporation of microchips contribute to the elevated manufacturing costs of smart pills. Smart pills represent a fusion of drug and device technology, offering a novel approach to drug delivery by embedding sensors and cameras into small ingestible devices. While these devices enable improved diagnostics, monitoring, and treatment of critical medical conditions by allowing real-time patient monitoring, their high cost limits their utilization in underdeveloped regions. Hence, the elevated cost is considered a hindrance to the growth of the smart pills market.

Extensive research and development efforts are underway to harness miniature chips like Addressable Transmitters Operated as Magnetic Spins (ATOMS) for use in smart pills. ATOMS are silicon chip devices that use magnetic resonance imaging (MRI) principles to pinpoint the location of atoms within a patient's body using magnetic fields. They can be employed in ingestible smart pills for disease diagnosis and treatment from within the body, monitoring the gastrointestinal tract, blood, brain, and various health indicators like pH, temperature, pressure, and sugar concentrations. Additionally, they can be programmed to release medications. For instance, scientists at Caltech (California Institute of Technology) have developed a miniature medical chip for potential use as a smart pill.

Major companies in the smart pills market are concentrating on developing smart pills with customizable programs to gain a competitive advantage. Smart pills with customizable programs enable personalized drug delivery and health monitoring, enhancing patient care and treatment effectiveness. For example, in September 2022, HealthBeacon PLC, an Irish digital therapeutics company, introduced the HB Smart Pills Solution, aiding patients in managing up to nine oral medications at home. This technology aims to improve medication adherence, addressing the issue where one in two patients struggles to adhere to their medication schedules. The HB Smart Pills Solution seamlessly integrates with patient support programs, offering customizable options for patients as standalone solutions or as part of existing offerings.

Major companies operating in the smart pills market include Medtronic PLC, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.

North America was the largest region in the smart pills market in 2023. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart pills market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Smart Pills Market Characteristics

3. Smart Pills Market Trends And Strategies

4. Smart Pills Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Pills Market Size and Growth

  • 5.1. Global Smart Pills Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Pills Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Pills Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Pills Market Segmentation

  • 6.1. Global Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Esophageal Diseases
  • Colon Diseases
  • Small bowel Diseases
  • Other Disease Indications
  • 6.2. Global Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine
  • 6.3. Global Smart Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Capsule Endoscopy
  • Patient Monitoring
  • Drug Delivery
  • 6.4. Global Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostic Center
  • Research Institute

7. Smart Pills Market Regional And Country Analysis

  • 7.1. Global Smart Pills Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Pills Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Pills Market

  • 8.1. Asia-Pacific Smart Pills Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Pills Market

  • 9.1. China Smart Pills Market Overview
  • 9.2. China Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Pills Market

  • 10.1. India Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Pills Market

  • 11.1. Japan Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Pills Market

  • 12.1. Australia Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Pills Market

  • 13.1. Indonesia Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Pills Market

  • 14.1. South Korea Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Pills Market

  • 15.1. Western Europe Smart Pills Market Overview
  • 15.2. Western Europe Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Pills Market

  • 16.1. UK Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Pills Market

  • 17.1. Germany Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Pills Market

  • 18.5. France Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Pills Market

  • 19.9. Italy Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Pills Market

  • 20.13. Spain Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Pills Market

  • 21.1. Eastern Europe Smart Pills Market Overview
  • 21.2. Eastern Europe Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Pills Market

  • 22.1. Russia Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Pills Market

  • 23.1. North America Smart Pills Market Overview
  • 23.2. North America Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Pills Market

  • 24.1. USA Smart Pills Market Overview
  • 24.2. USA Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Pills Market

  • 25.1. Canada Smart Pills Market Overview
  • 25.2. Canada Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Pills Market

  • 26.1. South America Smart Pills Market Overview
  • 26.2. South America Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Pills Market

  • 27.1. Brazil Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Pills Market

  • 28.1. Middle East Smart Pills Market Overview
  • 28.2. Middle East Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Pills Market

  • 29.1. Africa Smart Pills Market Overview
  • 29.2. Africa Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Pills Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Pills Market Competitive Landscape And Company Profiles

  • 30.1. Smart Pills Market Competitive Landscape
  • 30.2. Smart Pills Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Olympus Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. CapsoVision Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Proteus Digital Health Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Smart Pills Market Competitive Benchmarking

32. Global Smart Pills Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Smart Pills Market

34. Smart Pills Market Future Outlook and Potential Analysis

  • 34.1 Smart Pills Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Smart Pills Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Smart Pills Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer